Product Images Oxaliplatin

The text describes a chemotherapy regime consisting of FU bolus injection, Leucovorin infusion and Oxaliplatin infusion. The dosage information is given as FU bolus 400mg/m2 over 2 to 4 minutes on day 1 and day 2, followed by Leucovorin infusion of 200mg/m2 and FU infusion of 600mg/m2 on day 1 and day 2. The dosage of Oxaliplatin is 85mg/m2, but the timings are not specified.*

This appears to be a chemical formula for a compound with the molecular formula CsH14sN,O4Pt of molecular weight 397.3.*

This appears to be a graph or figure showing the probability of disease-free survival (DFS) over time for different treatment arms, with a legend indicating the number of events and hazard ratios. The x-axis shows the duration in months, and the y-axis shows the probability of DFS. There is also a stratified log-rank test mentioned with a p-value.*

This appears to be a chart depicting the DFS (disease-free survival) Kaplan-Meier curves of treatment arm F DUKES and treatment arm DUKES in stage III patients. The data was collected until June 1, 2006, with a probability score of 10 and some numerical values listed for Stagell Hasacd Rato and Logrunk Tt p0.005. It also includes a numeric chart with values for DS (monthis) and T& T2.*

This is a product description for Oxaliplatin Injection, USP which is used for Intravenous use only. It is a single-dose vial and must be used with 5% Dextrose injection. It must not be used with Sodium Chloride/Chloride-containing solutions. It is a cytotoxic agent and should be used with caution. The product should be stored in a controlled room temperature and should be protected from light and carbon. The manufacturer is Ingenus and the product is distributed by Spectrum Pharmaceuticals, Inc.*

This is a description of a medication named Oxaliplatin Injection. It is a sterile aqueous solution used for intravenous purposes and it is diluted with 5% dextrose injection. The medication must not be diluted with sodium chloride or chloride-containing solutions. It is a toxic agent and unused portion should be discarded. The dosage and administration are given in the text. The medication should be stored at room temperature and protected from light. It is manufactured by Ingenus Pharmaceuticals in Alabama, USA. The medication should be dispensed with patent information attached. However, some parts of the text are not readable.*